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Abstract 
Background: Eczema phenotypes based on eczema onset and persistence might better identify groups prone to 
allergic and respiratory conditions than a binary definition of eczema. We examined the associations of childhood 
eczema phenotypes with allergic sensitization, allergy, asthma and lung function at school age.
Methods: This study among 4277 children was embedded in a multi-ethnic population-based prospective cohort 
study. Five eczema phenotypes (never, early transient, mid-transient, late transient, persistent) based on parental-
reported physician-diagnosed eczema from age 6 months until 10 years were identified. At age 10 years, allergic 
sensitization was measured by skin prick tests, physician-diagnosed allergy and asthma by parent-reported question-
naires, and lung function by spirometry. Adjusted linear, logistic and multinomial regression models were applied.
Results: Compared with never eczema, all eczema phenotypes were associated with increased risks of asthma (odds 
ratios (OR) range (95% confidence interval): 2.68 (1.58, 4.57) to 11.53 (6.65, 20.01)), food and inhalant allergic sensitiza-
tion (1.72 (1.25, 2.36) to 12.64 (7.20, 22.18)), and physician-diagnosed inhalant allergy (1.92 (1.34, 2.74) to 11.91 (7.52, 
18.86)). Strongest effect estimates were observed of early and persistent eczema with the risk of physician-diagnosed 
food allergy (OR 6.95 (3.76, 12.84) and 35.05 (18.33, 70.00), respectively) and combined asthma and physician-diag-
nosed allergy (7.11 (4.33, 11.67) and 29.03 (15.27, 55.22), respectively). Eczema phenotypes were not associated with 
lung function measures.
Conclusion: Eczema phenotypes were differentially associated with risks of respiratory and allergic conditions in 
school-aged children. Children with early transient and persistent eczema might benefit from more intense follow-up 
for early identification and treatment of asthma and allergies.
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Background
Childhood eczema is a chronic disease with variable onset 
and persistence over time. The prevalence of eczema is up 
to 25% in infancy and diminishes over time [1]. Eczema is 
strongly associated with asthma and allergic sensitization 
[2]. It has been suggested that children with eczema and 
food allergies in early life develop asthma and allergic 
rhinitis in later life, which has been referred to as the 
atopic march [3]. However, previous results of longitu-
dinal cohorts only found a small proportion of children 
with eczema that follow this atopic march [4]. This might 
partly be explained by the definition of eczema used in 
these studies. In recent years, eczema phenotypes have 
been introduced in epidemiologic research to replace 
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the binary definition of eczema, as they incorporate the 
variability in age of onset and persistence of eczema, and 
therefore allow identification of specific underlying risk 
factors which can be used to optimize personalized pre-
ventative strategies and improve public health [5]. Also, 
eczema phenotypes could better identify children that 
may be at risk for developing asthma and allergy. Results 
of previous studies using longitudinal birth cohorts 
showed that all identified eczema phenotypes in early 
life were associated with up to sevenfold increased risks 
of asthma and allergy in later life, compared to the never 
eczema phenotype [6, 7]. The strongest association was 
observed for the persistent eczema phenotype in rela-
tion to asthma and allergy. However, the eczema pheno-
types are not yet determined in non-Caucasian children, 
related to lung function or comprehensive allergy out-
comes in older childhood.
Therefore, we examined in a multi-ethnic population-
based prospective cohort of 4277 children the asso-
ciations of eczema phenotypes from birth until 10 years 
with lung function, asthma, allergic sensitization, and 
allergy at school-age.
Methods
Design
This study was embedded in the Generation R Study, a 
population-based prospective cohort study from early 
fetal life onwards in Rotterdam, the Netherlands [8]. The 
study has been approved by the Medical Ethical Com-
mittee of the Erasmus MC University Medical Centre 
in Rotterdam. Written informed consent was obtained 
from parents or legal guardians. Children were excluded 
from the current analyses if information was missing on 
physician-diagnosed eczema for more than 3 time points 
and if information on lung function, asthma and allergic 
sensitization were missing. A total of 4277 children were 
included for the current analyses (Additional file 1: Fig-
ure S1).
Eczema phenotypes
Information on eczema was obtained from parental-
reported questionnaires at the age of 6 months, and 1, 2, 
3, 4 and 10 years (‘Was your child diagnosed with eczema 
in the last 6 months/last year by a general practitioner or 
physician in the hospital?’) [9]. As previously described, 
in children with available data on at least 3 time points 
between age 6  months to 10  years, latent class growth 
analysis was used to assign children to their latent classes 
based on their respective posterior probabilities [10]. Five 
eczema phenotypes were identified based on the vari-
ous eczema trajectories: never, early transient, mid-tran-
sient, late transient and persistent eczema (Additional 
file 1: Figure S2). Data on ever eczema was collected by 
parental-reported questionnaires at 10 years of age (‘Has 
your child ever had eczema diagnosed by a doctor?’).
Lung function, asthma and allergy
Children visited the research center at a median age of 
9.7  years (2.5–97.5th percentile range 9.3–10.3  years). 
Information on lung function was measured by spirom-
etry and included forced expiratory volume in 1  sec-
ond  (FEV1), forced vital capacity (FVC),  FEV1/FVC, 
and forced expiratory flow after exhaling 75% of FVC 
 (FEF75). Lung function measures were converted into 
sex-, height-, age-, and ethnicity-adjusted z-scores [11, 
12]. Information on current asthma, and physician-diag-
nosed inhalant and food allergy were adapted from the 
International Study on Asthma and Allergy in Childhood 
(ISAAC) [13]. Current asthma (no; yes) was defined as 
ever diagnosis of asthma with wheezing or medication 
use in the past 12  months at 10  years of age. Parental 
reported questionnaires were used to define physician-
diagnosed inhalant allergy (“Was your child ever diag-
nosed by a physician with an allergy to pollen (hay fever)/
house dust mite/cat/dog?”) (no; yes) and food allergy 
(“Was your child ever diagnosed by a physician with an 
allergy to cashew nut/peanut?”) (no; yes) at age 10 years. 
Additionally, information on allergic rhinitis, a more 
detailed question on inhalant allergy, was obtained by 
a parental reported questionnaire (“Did your child had 
any sneezing, running nose or stuffed nose in the last 
12  months, even though he or she did not have a cold 
or flu?” (no; yes). Information on allergic sensitization 
was collected by skin prick tests using the scanned area 
method [14, 15]. We examined the most prevalent food 
allergens for children at age 10  years at a population-
based level, and therefore allergens for milk and egg were 
excluded [16, 17]. Inhalant allergens included house dust 
mite, 5-grass mixture, birch, cat, and dog. Food allergens 
included hazelnut, cashew nut, peanut and peach. Details 
on the collection of lung function, asthma and allergy 
measures are provided in the Additional file 1.
Covariates
Information on parity, maternal education, and parental 
history of eczema, allergy or asthma was available from 
parental questionnaires obtained at enrolment. Child’s 
sex was obtained from midwives and hospital records, 
and ethnic origin based on the parents’ country of birth 
according to Statistics Netherlands [18]. Postnatal ques-
tionnaires provided information on breastfeeding at 2, 6 
or 12 months after birth.
Statistical analysis
Linear, logistic and multinomial regression models were 
used to examine the association of eczema phenotypes 
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with lung function measures, risk of asthma, allergic 
sensitization or physician-diagnosed allergy, and com-
bined allergic outcomes, respectively, using the pack-
ages ‘mice’ (version 3.3.0), ‘stats’ (version 3.5.2) and ‘nnet 
(version 7.3–12) in R version 3.5.2 [19–21]. The analyses 
were adjusted for potential confounders, selected from 
literature if they were related with both eczema pheno-
types and the outcome and were not in the causal path-
way. In order to examine inhalant allergies in detail, we 
also examined the correlation between physician-diag-
nosed inhalant allergy and allergic rhinitis, and the asso-
ciations of eczema phenotypes with allergic rhinitis. To 
study the role of ethnicity in more detail, we performed a 
sensitivity analysis by stratifying for ethnicity (European 
or non-European). We only present the results based on 
imputed data, because the size and direction of effects 
were similar in complete-case-analysis. We did not adjust 
for multiple testing, because the respiratory and allergic 
measures were related to each other, and examined under 
the same hypothesis. More information on the statistical 
analyses is provided in the Additional file 1. All measures 
of association are presented as pooled z-score change 
or odds ratios (OR) with their corresponding 95% confi-
dence intervals (95% CI).
Results
Subject characteristics
Characteristics of children and their mothers are sum-
marized in Table  1. For each eczema phenotype, the 
prevalence of current asthma, physician-diagnosed food 
allergy and inhalant allergy are presented in Fig.  1. Co-
occurrence of these comorbidities was most prevalent 
in the persistent eczema group (range 1–19%). Main 
results of loss-to-follow-up analysis showed that children 
not included in the analyses more often had mothers of 
younger age, multiparity, lower education and no history 
of eczema, allergy or asthma, and more often had lower 
birth weight, a male sex and a non-European ethnicity 
mostly of Moroccan, Turkish and Cape Verdean ethnicity 
(Additional file 1: Table S1).
Eczema phenotypes, lung function and current asthma
Compared with never eczema, ever eczema was associ-
ated with a higher FVC and  FEV1 (Z score change (95% 
CI): 0.08 (0.01, 0.16) to 0.08 (0.00, 0.16), respectively), 
but not with  FEV1/FVC and  FEF75. Ever eczema was 
associated with an increased risk of current asthma 
(OR (95% CI): 6.38 (4.61, 8.83) (Table 2). When exam-
ining eczema phenotypes, we observed that compared 
with the never eczema phenotype, only late transient 
eczema was associated with a higher FVC (Z score 
change (95% CI) 0.11 (0.00, 0.21)) (Table 2). All eczema 
phenotypes were associated with an increased risk of 
current asthma at the age of 10 years with the strong-
est effect estimates for early transient and persistent 
eczema (OR (95% CI) 4.82 (3.29, 7.08) and 11.53 (6.65, 
20.01)). Similar size and direction of effect estimates 
were observed among children of European and non-
European ethnicity (Additional file 1: Tables S2 and S3).
Table 1 Characteristics of children and their mothers
Values are percentages (absolute values), mean (SD) or median (2.5–97.5th 
percentile) after imputation. aData was missing and not imputed for gestational 
age at birth (0.2%), birth weight (0.1%), ever eczema (11.6%), allergic rhinitis 
(26.9%), and lung function (11.5%). bData on the following outcomes were 
not imputed for the individual analysis and were missing for: current asthma 
(9.7%), inhalant (26.9%) and food sensitization (27.1%), physician diagnosed 
inhalant (10.9%) and food allergy (12.7%). They were imputed for the combined 
outcome analysis and values are for current asthma (yes) 6% (n = 237), inhalant 
sensitization (yes) 33% (n = 1394), food sensitization (yes) 8% (n = 336), 
physician-diagnosed inhalant allergy (yes) 12% (n = 521) and physician-
diagnosed food allergy (yes) 3% (n = 105)
Subjects
n = 4277
Maternal characteristics
 Age at enrollment, years mean (SD) 31.7 (4.5)
 Parity, nulliparous  % (n) 59 (2526)
 Maternal education, higher  % (n) 59 (2510)
 History of eczema, allergy and asthma, yes  % (n) 61 (2597)
Child characteristics
 Sex, female  % (n) 51 (2181)
 Gestational age at birth, weeks median (2.5–97.5th 
percentile)a
40.1 (35.5–42.3)
 Birth weight, grams mean (SD)a 3443.1 (566.9)
 Ethnicity, non-European  % (n) 24 (1006)
 Breastfeeding, ever  % (n) 93 (3961)
 Eczema, ever  % (n)a 23 (859)
Eczema phenotypes  % (n)
 Never 76 (3229)
 Early transient 9 (363)
 Mid-transient 6 (259)
 Late transient 8 (333)
 Persistent 2 (93)
Current asthma, yes  % (n)b 5 (203)
Inhalant sensitization, yes  % (n)b 32 (985)
Food sensitization, yes  % (n)b 7 (209)
Physician diagnosed inhalant allergy, yes  % (n)b 12 (447)
Allergic rhinitis, yes  % (n)a 20.6 (734)
Physician diagnosed food allergy, yes  % (n)b 2 (79)
Lung function, Z-scores mean (SD)a
 FVC 0.18 (0.91)
 FEV1 0.13 (0.96)
 FEV1/FVC − 0.12 (0.95)
 FEF75 − 0.00 (0.91)
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Fig. 1 Prevalence of current asthma, physician diagnosed food and inhalant allergy in eczema phenotype. Values are percentages (absolute values) 
and based on observed data. n = number of participants with information on current asthma or physician diagnosed allergies, and at least 3 
eczema measurements
Table 2 Associations of eczema phenotypes with lung function and current asthma in children at age 10 years
Values are Z-score mean differences for lung function measurements and odds ratios (95% confidence intervals) for current asthma from linear and logistic regression 
models for never/ever eczema. Values are average Z-score mean differences for lung function measurements and average odds ratios (95% confidence intervals) 
for current asthma from linear and logistic regression models, respectively, after multiple sampling based on 150 imputed datasets for eczema phenotypes. Lung 
function outcomes are force expiratory volume in 1 second  (FEV1), forced vital capacity (FVC), force expiratory flow at 75% of the exhaled FVC  (FEF75). Full models 
were adjusted for parental history of allergy, asthma or eczema, maternal education, parity, child’s sex, ethnicity and breastfeeding. Italic values indicate statistical 
significance at the α = 0.05 level
FVC
Z-score (95% CI)
FEV1
Z-score (95% CI)
FEV1/FVC
Z-score (95% CI)
FEF75
Z-score (95% CI)
Current asthma at 10 years
odds ratio (95% CI)
Never eczema Reference Reference Reference Reference Reference
Ever eczema 0.08 (0.01, 0.16) 0.08 (0.00, 0.16) 0.00 (− 0.07, 0.08) 0.02 (− 0.05, 0.09) 6.38 (4.61, 8.83)
Never Reference Reference Reference Reference Reference
Early transient 0.04 (− 0.07, 0.14) 0.00 (− 0.10, 0.11) − 0.02 (− 0.23, 0.19) − 0.05 (− 0.15, 0.05) 4.82 (3.29, 7.08)
Mid-transient − 0.07 (− 0.20, 0.05) − 0.08 (− 0.21, 0.05) − 0.04 (− 0.15, 0.07) − 0.03 (− 0.15, 0.09) 2.68 (1.58, 4.57)
Late transient 0.11 (0.00, 0.21) 0.05 (− 0.06, 0.16) − 0.11 (− 0.22, 0.00) − 0.03 (− 0.13, 0.08) 3.07 (1.94, 4.87)
Persistent 0.04 (− 0.16, 0.24) 0.00 (− 0.21, 0.21) − 0.02 (− 0.23, 0.19) − 0.00 (− 0.20, 0.19) 11.53 (6.65, 20.01)
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Eczema phenotypes, allergic sensitization 
and physician-diagnosed allergies
Compared with never eczema, ever eczema was associ-
ated with increased risks of allergic sensitization and 
physician-diagnosed allergies for both inhalant and food 
allergens. The strongest association was observed for ever 
eczema with physician diagnosed food allergy (OR (95% 
CI) 11.89 (6.85, 20.61)) (Table 3). Of the eczema pheno-
types, the early transient and persistent phenotypes were 
most strongly associated with increased risks of inhalant 
allergic sensitization (OR (95% CI) 2.62 (2.01, 3.42) and 
4.53 (2.65, 7.51)), food allergic sensitization (OR (95% CI) 
5.73 (3.94, 8.31) and 12.64 (7.20, 22.18)), physician-diag-
nosed inhalant allergy (OR (95% CI) 3.72 (2.78, 4.97) and 
11.91 (7.52, 18.86)) and physician-diagnosed food allergy 
(OR (95% CI) 6.95 (3.76, 12.84) and 35.05 (18.33, 70.00)) 
(Table 3). Physician-diagnosed inhalant allergy and aller-
gic rhinitis were correlated (Cramer’s  V (Chi square p 
value) 0.50 (≤ 0.001)). The observed effect estimates of 
the associations of eczema phenotypes with allergic rhi-
nitis were in the same direction, but less greater, versus 
those of eczema phenotypes with physician-diagnosed 
inhalant allergy (OR range (95% CI) 1.43 (1.02, 2.00) and 
4.91 (3.14, 7.66) versus 1.92 (1.34, 2.74) and 11.91 (7.52, 
18.86), respectively) (Additional file  1: Table  S4). Simi-
lar size and direction of effect estimates were observed 
among children of European and non-European eth-
nicity (Additional file  1: Tables S2 and S3). Effect esti-
mates were in the same direction and stronger if a child 
had both allergic sensitization and physician-diagnosed 
allergy (Additional file 1: Table S5).
Eczema phenotypes, asthma and physician-diagnosed 
allergy combined
Compared with never eczema, ever eczema was asso-
ciated with increased risks of both asthma only and 
physician-diagnosed allergy only (OR (95% CI) 5.83 
(3.49, 9.74) and 4.03 (3.17, 5.11)), and most strongly 
with asthma and physician-diagnosed allergy combined 
(8.98 (5.89, 13.69)) (Table  4). Compared with never 
eczema phenotypes, early transient and persistent 
eczema were most strongly associated with asthma only 
(OR (95% CI) 5.36 (3.07, 9.36) and 5.23 (1.55, 17.63)), 
physician-diagnosed allergy only (3.68 (2.67, 5.08) and 
10.02 (5.92, 16.96)), and asthma and physician-diag-
nosed allergy combined (7.11 (4.33, 11.67) and 29.03 
(15.27, 55.22)). Effect estimates for eczema pheno-
types were in the same direction and higher odds were 
observed when physician-diagnosed food and inhalant 
allergy were combined and when physician-diagnosed 
food and inhalant allergies were combined with asthma 
(Additional file 1: Table S6).
Discussion
In this multi-ethnic population-based prospective 
cohort study, eczema phenotypes were differentially 
associated with the risk of allergic and respiratory con-
ditions in school-aged children. The early transient 
and persistent eczema phenotypes were most consist-
ently associated with asthma, allergic sensitization, 
and physician-diagnosed allergies, including allergic 
rhinitis. Results were similar for children of European 
and non-European ethnicity. Stronger effect estimates 
were observed for early transient and persistent eczema 
phenotypes with food allergy related measures and 
combined asthma and physician-diagnosed allergies. 
Compared with never eczema, ever eczema was asso-
ciated with higher FVC and  FEV1, but not with  FEV1/
FVC. Eczema phenotypes were not associated with any 
lung function measurement.
Table 3 Associations of  eczema phenotypes with  allergic sensitization and  physician-diagnosed allergies in  children 
at age 10 years
Values are odds ratios (95% confidence intervals) from logistic regression models for never/ever eczema and average odds ratios (95% confidence intervals) from 
logistic regression models after multiple sampling based on 150 imputed datasets for eczema phenotypes. Full models were adjusted for parental history of allergy, 
asthma or eczema, maternal education, parity, child’s sex, ethnicity and breastfeeding. Italic values indicate statistical significance at the α = 0.05 level
Inhalant sensitization
odds ratio (95% CI)
Food sensitization
odds ratio (95% CI)
Physician-diagnosed 
inhalant allergy
odds ratio (95% CI)
Physician-diagnosed
food allergy
odds ratio (95% CI)
Never eczema Reference Reference Reference Reference
Ever eczema 2.91(2.41, 3.52) 4.90 (3.60, 6.67) 4.54 (3.65, 5.63) 11.89 (6.85, 20.61)
Never Reference Reference Reference Reference
Early transient 2.62 (2.01, 3.42) 5.73 (3.94, 8.31) 3.72 (2.78, 4.97) 6.95 (3.76, 12.84)
Mid-transient 1.72 (1.25, 2.36) 2.13 (1.21, 3.76) 2.66 (1.86, 3.80) 1.44 (0.43, 4.80)
Late transient 1.77 (1.33, 2.35) 2.52 (1.56, 4.07) 1.92 (1.34, 2.74) 4.50 (2.19, 9.28)
Persistent 4.53 (2.65, 7.51) 12.64 (7.20, 22.18) 11.91 (7.52, 18.86) 35.05 (18.33, 70.00)
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Comparison with previous studies
When comparing results with previous studies, the dif-
ference in eczema phenotype definition and follow-up 
duration need to be taken into account. Previous cohort 
studies showed that children with early-onset and persis-
tent eczema phenotypes have increased risks of asthma at 
ages 6 to 13 year [6, 7]. Results for mid- and late transient 
eczema phenotypes and the risk of asthma are inconsist-
ent. Our observations in a multi-ethnic population are 
in line with previous findings and support that children 
with any eczema phenotype, but especially those with 
early onset and persistent eczema have increased risks of 
asthma at school-age [22, 23]. While eczema is strongly 
related to asthma and therefore hypothetically also with 
altered lung function, the relationship between eczema 
and lung function has not been studied. We observed 
that children with ever eczema had slightly higher  FEV1 
and FVC, but no changes in  FEV1/FVC. These findings 
might be incidental, since there were no associations of 
eczema phenotypes with lung function measures. Other 
mechanisms might underlie the observed associations of 
ever eczema and eczema phenotypes with asthma, such 
as inhalant allergies and possible modulating effects of 
early allergic sensitization and allergic rhinitis [24]. Also 
all children included in our analysis had higher  FEV1 and 
FVC z-scores, which might be explained by a relatively 
healthy study population or well-controlled asthma.
Previous studies showed that persistent eczema was 
associated with elevated total Immunoglobulin E levels at 
ages 7–8  years, and with an increased risk of sensitiza-
tion to inhalant allergens, but not to food allergens at age 
6 years [6, 7]. We showed that children with early tran-
sient and persistent eczema phenotypes had both allergic 
sensitization and physician-diagnosed allergies, with the 
strongest effect estimates for food allergy at age 10 years. 
These observed differences might be due to differences 
in number of children included for analysis, food allergy 
prevalence, eczema phenotypes definition and because 
our population has a longer follow-up which allowed 
the identification of more diverse phenotypes. A cohort 
study in children until age 6 years showed that children 
with early transient and persistent eczema had increased 
risks of food allergy and allergic rhinitis [7]. We observed 
similar results among children until age 10  years with 
allergic sensitization and physician-diagnosed food and 
inhalant allergies. Many children among the early tran-
sient and persistent eczema phenotype group had both 
asthma and multiple allergic conditions, and a large per-
centage of these (31–61%) had at least one diagnosis of 
asthma, food or inhalant allergy. Therefore, our results do 
not support the atopic march hypothesis in all children 
with eczema, but does show that in particular children 
with early transient and persistent eczema are likely to 
develop asthma and/or allergies later in childhood.
Possible mechanisms
Early transient and especially persistent eczema consist-
ently showed the strongest associations with asthma and 
allergic conditions. A common trait of both phenotypes 
is the early onset of eczema, suggesting that the period 
before the age of 2  years of age was important for the 
development of asthma and allergic conditions. Matu-
ration rates of the skin, lungs and immune system from 
birth until 2 years are high and any change or disruption 
of these maturation processes might have long term con-
sequences [25]. Proposed mechanisms include dysfunc-
tion of the epithelial barrier due to microbial and/or 
genetic factors and transcutaneous sensitization, lead-
ing to type 2 inflammation, and thereby predisposing to 
asthma and allergic conditions [25–27]. Our recent study 
Table 4 Association of eczema phenotypes with combined asthma and physician-diagnosed allergy groups in children 
at age 10 years
Values are odds ratios (95% confidence intervals) from logistic regression models for never/ever eczema and average odds ratios (95% confidence intervals) from 
multinomial regression models after multiple sampling based on 150 imputed datasets for eczema phenotypes. Reference group is no asthma and no allergy 
(n = 3627). n = number of participants with information on at least 3 eczema measurements. Missing data on asthma and physician-diagnosed allergy was imputed. 
Full models were adjusted for parental history of allergy, asthma or eczema, maternal education, parity, child’s sex, ethnicity and breastfeeding. Italic values indicate 
statistical significance at the α = 0.05 level
Asthma, but no allergy
n = 97
Allergy, but no asthma
n = 413
Asthma and allergy
n = 140
Never eczema Reference Reference Reference
Ever eczema 5.83 (3.49, 9.74) 4.03 (3.17, 5.11) 8.98 (5.89, 13.69)
Never Reference Reference Reference
Early transient 5.36 (3.07, 9.36) 3.68 (2.67, 5.08) 7.11 (4.33, 11.67)
Mid-transient 1.37 (0.45, 4.19) 2.21 (1.47, 3.32) 4.31 (2.33, 7.99)
Late transient 2.94 (1.47, 5.89) 1.76 (1.18, 2.64) 3.48 (1.88, 6.44)
Persistent 5.23 (1.55, 17.63) 10.02 (5.92, 16.96) 29.03 (15.27, 55.22)
Page 7 of 8Hu et al. Clin Transl Allergy            (2020) 10:7  
showed an association of the four most common filag-
grin mutations in Europeans with early and late transient 
eczema, but not with persistent eczema [10]. Unfortu-
nately, we were not able to study filaggrin mutations as 
mediators for the association of eczema phenotypes with 
asthma and allergic conditions due to lack of power. Also 
sensitivity analysis in more detailed non-European eth-
nic subgroups was not possible due to small sample size. 
Therefore, future studies with larger sample sizes are 
needed to examine the potential mediating role of filag-
grin mutations on the associations of eczema phenotypes 
with asthma and allergic conditions, and the role of dif-
ferent ethnicities.
Strengths and limitations
The strengths of this study include the eczema pheno-
types among a multi-ethnic population with detailed 
information on asthma, lung function, and multiple aller-
gic conditions. By using multivariate regression models 
with multiple imputation and sampling we achieved more 
precise and unbiased effect estimates. However, some 
methodological considerations need to be taken into 
account. Children not included in the analyses partly had 
less favourable socio-economic factors and more often 
parents with no history or eczema, allergy or asthma. 
Selection bias due to lost to follow-up might have been 
present if the associations of eczema phenotypes with 
respiratory and allergic conditions were different in chil-
dren that were not included in the analyses compared to 
the children that were included in the analyses. We aimed 
to minimize bias by imputation methods [20]. Despite 
validated questions, misclassification of eczema, asthma 
and physician diagnosed allergies remains possible due 
to self-response [13, 28]. We included the most relevant 
allergens for children of age 10 years at population level, 
and excluded allergens with low sensitization rates at this 
age, such as milk and egg [16, 17]. Residual confounding 
might be present since there might be factors not meas-
ured or not included in our analysis. For example, there 
was no information available to determine the severity 
of eczema. Furthermore, we were unable to perform our 
analyses in more detailed ethnic groups due to lack of 
power [29].
Conclusion
Eczema phenotypes were differentially associated with 
risks of asthma and allergic conditions among school-
aged children, and were similar in children from Euro-
pean and non-European ethnicity. The strongest and 
most consistent associations were found in children 
with early transient and persistent eczema. This sug-
gests that children with early transient and persistent 
eczema might benefit from more intense follow-up 
for early identification and treatment of asthma and 
allergies.
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